The 22nd Japan Osteoporosis Society / 38th Japan Society for Bone and Metabolism Academic Meeting is scheduled to be held from October 9th (Friday) to October 11th (Sunday), 2020 at Kobe International Exhibition Hall and Kobe International Exhibition Hall. However, they have decided to hold the event on the WEB, considering the spread of the new coronavirus infection (COVID-19) and the health and safety of all concerned parties. The 38th Annual Meeting of the Japanese Society for Bone and Mineral Research (JSBMR) is organized by The Japanese Society for Bone and Mineral Research (JSBMR). The session comences from Oct 09 - 12, 2020 at Kobe International Conference Center, kobe, Hyogo, Japan. Additional details will be posted as soon as they are available.

Japan Digestive Disease Week (JDDW) 2020 is organized by Japan Digestive Disease Week (JDDW) and will be held from Nov 05 - 08, 2020 at Kobe Convention Center, Kobe, Hyogo, Japan. Additional details will be posted as soon as information is available.

Cell & Gene Therapy and Cancer Immunotherapy Asia 2020 is organized by Select Biosciences and will be held from Nov 12 - 13, 2020 at obe Bay Sheraton Hotel & Towers, kobe, Hyogo, Japan.  Description: This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, ESCs and iPSCs and their deployment for cell & gene therapy, cancer immunotherapy including CAR-T therapy, and clinical application and technologies for gene therapy. The conference addresses the whole ecosystem of Cell & Gene Therapy and Cancer Immunotherapy with a focus on technology platforms being developed to bring cell & gene therapy and regenerative medicine to the clinic. Topics: • Biomarkers & Companion Diagnostics for Targeting Cancer Immunotherapy • Checkpoint and Non-Checkpoint Immunotherapies • Chimeric Antigen Receptor (CAR) T-Cells in Cancer Immunotherapy • Clinical Trials and Commercialization of Cell Therapies • Combination Cancer Immunotherapy • ESC and iPSC-derived Cells for Cellular Therapy and Clinical Deployment • Gene Therapy into the Clinic ○ Clinical Pipeline ○ Regulatory Landscape ○ Technology Platforms • Immunomodulatory Antibodies • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy • Small Molecules in Cancer Immunotherapy • Stem Cells for Cellular Therapy • Targeting Signaling Pathways in Cancer as Therapeutic Intervention Additional details will be posted as soon as information is available.

Adult Stem Cells & Exosome-based Therapeutics 2020 is organized by Select Biosciences and will be held from Nov 12 - 13, 2020 at obe Bay Sheraton Hotel & Towers, kobe, Hyogo, Japan. Overview: SelectBIO Adult Stem Cells & Exosome/EV-based Therapeutics Asia 2020 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: • Extracellular Vesicles Produced by Adult Stem Cells and their Functional Activities • Exosome/EV Engineering • Exosomes/EV-based Therapeutics Development and Regenerative Medicine This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas: • Technologies for Isolation and Characterization as Well as High-Volume Production of EVs for Potential Therapeutics Applications • Exosomes/EVs Derived from Adult Stem Cells and Their Theraeputic/Regenerative Properties • Role in Cancer and Various Disease Classes -- Regenerative Medicine • Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development • Regulatory Landscape in the Use of Exosomes/EVs for Therapeutics The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date based on research involving stem cells and stem cell-derived extracellular vesicles (EVs) for clinical utility and regenerative medicine. Additional details will be posted as soon as information is available.

The 95th Annual Meeting of the Japanese Orthopaedic Association (JOA) is organized by The Japanese Orthopaedic Association (JOA) and will be held from May 19 - 20, 2022 at Kobe International Conference Center, kobe, Hyogo, Japan. Additional details will be posted as soon as information is available.

60th Annual Meeting of the Japan Society of Clinical Oncology (JSCO2022) is organized by Japan Society of Clinical Oncology (JSCO) and will be held from Oct 20 - 22, 2022 at Kobe International Conference Center, kobe, Hyogo, Japan. Additional details will be posted as soon as they are available.